ICU Stock Forecast: Seastar Medical Holding Corp. Price Predictions for 2026-2027
The median 12-month analyst price target for Seastar Medical Holding Corp. is $10. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 26 of 100 as at 21 Nov 2026 — in the lower half.
One number for the whole business
Consensus tells you what everyone already believes. The model scores Seastar Medical Holding Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Accruals (69): Reported profit is backed by cash, and the company is not expanding recklessly.
Momentum (17): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
ICU stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on ICU, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 14 May 2026 | Maxim Group | Maintains | Buy | $6.00 → $8.00 |
| 20 Apr 2023 | Maxim Group | Initiates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for ICU.
This page is one stock. Monday covers all of them.
ICU appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
ICU vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 20 Nov 2026, Seastar Medical Holding Corp. returned −70.6% against +6.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
ICU analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- 2.3×
- Price / book
- 0.3×
- EV / EBITDA
- —
Cheaper than 44% of US stocks
Cheaper than 90% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- 91.2%
- Operating margin
- —
- Net margin
- —
Higher than 97% of US stocks
- Return on equity
- −246.1%
- Return on assets
- −89.9%
- Dividend yield
- —
Higher than 6% of US stocks
Higher than 3% of US stocks
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Seastar Medical Holding Corp. has a market value of $5.0M and an enterprise value of $981K.
Revenue in the twelve months to 30 June 2026: $1.7M. The latest quarter grew 82.0% year on year.
Net income over the same four quarters: −$13.6M, a −795.5% net margin.
Diluted earnings per share, trailing twelve months: −$3.91.
Free cash flow in the twelve months to 30 June 2026: −$13.7M.
Seastar Medical Holding Corp. employs 17 people — $101K of revenue per employee.
Data provided by Twelve Data
ICU and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at ICU’s peer groups, ranked by the model: healthcare stocks · biotech stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own Seastar Medical Holding Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about ICU
What is the ICU stock price forecast for 2026-2027?
The median 12-month analyst price target for Seastar Medical Holding Corp. is $10, with estimates ranging from $8 to $12. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is ICU stock a buy right now?
Of the 1 analyst covering Seastar Medical Holding Corp., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Seastar Medical Holding Corp. 26 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank ICU?
As at 21 Nov 2026, Seastar Medical Holding Corp. ranks 26 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Accruals (69 of 100).
Will ICU stock go up?
No one can know that. What the data says: the median 12-month target from 1 analyst is $10, and Ticker Nerd's factor model ranks Seastar Medical Holding Corp. 26 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the ICU stock forecast for 2030?
No analyst covering Seastar Medical Holding Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ICU are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $8 to $12 over the next 12 months.
How has ICU stock performed over the past year?
Seastar Medical Holding Corp. returned -70.6% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Seastar Medical Holding Corp. do?
SeaStar Medical Holding Corporation is a commercial-stage medical device company focused on therapies for critically ill patients facing organ failure and severe inflammatory conditions. SeaStar Medical develops and commercializes extracorporeal treatment systems centered on its Selective Cytopheretic Device platform, which is designed to modulate harmful immune responses and reduce hyperinflammation.
About Seastar Medical Holding Corp.
SeaStar Medical Holding Corporation is a commercial-stage medical device company focused on therapies for critically ill patients facing organ failure and severe inflammatory conditions. SeaStar Medical develops and commercializes extracorporeal treatment systems centered on its Selective Cytopheretic Device platform, which is designed to modulate harmful immune responses and reduce hyperinflammation. The company’s current product portfolio includes QUELIMMUNE, an FDA-approved treatment for pediatric acute kidney injury associated with sepsis or septic condition requiring renal replacement therapy, along with additional SCD-based programs in adult kidney injury and other serious inflammatory indications. Based in Denver, Colorado, SeaStar Medical operates in the medical technology and specialty devices market, addressing unmet needs in hospital intensive care and renal replacement settings.
CEO Mr. Eric Schlorff · 17 employees · United States · https://seastarmedical.com